Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bilezikian

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
F1000Research|August 11, 2016
Primary HyperparathyroidismLeonardo Bandeira, John Bilezikian
Archives of Endocrinology and Metabolism|November 16, 2022
Medical management of primary hyperparathyroidismFrancisco Bandeira, Janiere de Moura Nóbrega, Lucian Batista de Oliveira, et al.
European Journal of Endocrinology|February 1, 2015
Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgeryAliya Khan, John Bilezikian, Henry Bone, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2009
Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidismClaudio Marcocci, Philippe Chanson, Dolores Shoback, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)Rajesh V Thakker, Paul J Newey, Gerard V Walls, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|September 14, 2013
Diagnosis and management of primary hyperparathyroidism--a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism, Francisco Bandeira, Luiz Griz, et al.
Endocrine Reviews|October 16, 2018
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding QuestionsRoger Bouillon, Claudio Marcocci, Geert Carmeliet, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatmentBarbara M Misof, Paul Roschger, Felicia Cosman, et al.
The New England Journal of Medicine|August 16, 2008
The effects of tibolone in older postmenopausal womenSteven R Cummings, Bruce Ettinger, Pierre D Delmas, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
F1000Research|August 11, 2016
Primary HyperparathyroidismLeonardo Bandeira, John Bilezikian
Archives of Endocrinology and Metabolism|November 16, 2022
Medical management of primary hyperparathyroidismFrancisco Bandeira, Janiere de Moura Nóbrega, Lucian Batista de Oliveira, et al.
European Journal of Endocrinology|February 1, 2015
Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgeryAliya Khan, John Bilezikian, Henry Bone, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2009
Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidismClaudio Marcocci, Philippe Chanson, Dolores Shoback, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)Rajesh V Thakker, Paul J Newey, Gerard V Walls, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|September 14, 2013
Diagnosis and management of primary hyperparathyroidism--a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism, Francisco Bandeira, Luiz Griz, et al.
Endocrine Reviews|October 16, 2018
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding QuestionsRoger Bouillon, Claudio Marcocci, Geert Carmeliet, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatmentBarbara M Misof, Paul Roschger, Felicia Cosman, et al.
The New England Journal of Medicine|August 16, 2008
The effects of tibolone in older postmenopausal womenSteven R Cummings, Bruce Ettinger, Pierre D Delmas, et al.
Pageof 1